BPC-157 (Body Protection Compound-157) is a peptide made up of 15 amino acids, derived from a protein found in human gastric juice. Since the early 1990s, this synthetic peptide has been researched for its potential in tissue repair, wound healing, and musculoskeletal recovery.
Fifteen amino acids. Six recovery pathways. Here’s how BPC-157 works across multiple biological systems simultaneously.

Response time varies by individual and the condition being addressed. Some patients report noticing changes within 2–4 weeks of consistent use. Your provider will monitor your progress and adjust your protocol as needed.
The most commonly reported side effects are mild: injection site redness, localized swelling, and transient discomfort. Preclinical studies across a wide range of dosing have not identified significant organ toxicity. Your provider will review your specific risk factors during your consultation.
Preclinical studies have not demonstrated hepatotoxicity or nephrotoxicity with BPC-157 across the studied dosing ranges. BPC-157 is primarily eliminated through renal excretion, with the highest concentrations observed in the kidneys, liver, and bile. Your provider may monitor liver and kidney function as part of your standard lab work.
BPC-157 has been studied for its effects on cardiovascular tissue in preclinical models, particularly through its angiogenic and nitric oxide signaling pathways. However, these applications remain investigational. Patients with cardiovascular concerns should discuss their full medical history with their provider.
BPC-157 and TB-500 are both peptides studied for tissue repair, but they work through different mechanisms. BPC-157 primarily drives angiogenesis and cellular repair signaling (VEGF, AKT, nitric oxide pathways), while TB-500 promotes cell migration and tissue remodeling by sequestering G-actin. Many providers combine them in a Wolverine Stack for complementary recovery support.
Yes. At iThriveMD, all peptide therapy requires a medical evaluation and provider prescription. BPC-157 is compounded in our sterile cleanroom facility and is not available over the counter.
BPC-157 has been studied across a wide dosing range (6 mcg/kg to 20 mg/kg) in preclinical models for up to 6 weeks, with no reported acute toxicity, organ damage, hepatotoxicity, nephrotoxicity, mutagenicity, or genotoxicity.
*Long-term human safety data remains limited. Your provider will evaluate whether BPC-157 is appropriate for you based on your complete medical history.*
